NCT05597839
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05597839
Title Study of DF9001 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dragonfly Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Gilbert Arizona 85234 United States Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
UC Irvine Medical Center Irvine California 92617 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
University of Louisville Hospital Louisville Kentucky 40202 United States Details
Mayo Clinic Minnesota Rochester Minnesota 55905 United States Details
AMR Kansas City Kansas City Missouri 64114 United States Details
Rutgers New Brunswick New Jersey 08903 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Cincinnati Cincinnati Ohio 45219 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
UMPC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field